US EditionMedicare announces price cuts for 15 prescription drugs, including Ozempic
The Centers for Medicare & Medicaid Services projects $12 billion savings from a 44% price cut on 15 high-cost drugs under Medicare starting in 2027.
- On Tuesday, the Centers for Medicare and Medicaid Services announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy, with cuts taking effect in 2027.
- Created under the Inflation Reduction Act, the negotiation program cuts prices following last year’s deals on 10 prescription drugs amid affordability concerns.
- The negotiated list shows steep cuts for several high-cost medicines, including Ozempic, Rybelsus, and Wegovy at $274 for a 30-day supply, down from the $959 list price, and the 15 drugs accounted for $42.5 billion, or 15%, of Medicare Part D spending in 2024.
- CMS said the discounts will save taxpayers $12 billion and reduce Medicare enrollees’ out-of-pocket costs by $685 million in 2027.
- The announcement contrasts with President Donald Trump’s voluntary deal approach, as Trump recently announced a Novo Nordisk deal with a $250 price while drugmakers have unsuccessfully challenged the statutory program.
171 Articles
171 Articles
Make drug price cuts visible: Biden-era law delivers savings for 15 Medicare drugs as Trump officials claim credit
A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.
Trump administration says lower prices for 15 Medicare drugs will save taxpayers billions
The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations and that it's expected to produce billions in savings for older adults. But the net prices unveiled Tuesday aren't…
Medicare announces lower prices for 15 costly drugs, including Ozempic and Wegovy
Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, reductions that are expected to produce billions in savings for taxpayers and older adults, the Trump administration said.
Medicare Announces Lower Prices for 15 Drugs
The Trump administration has revealed new, lower prices for 15 widely used prescription drugs, the result of Medicare negotiations with pharmaceutical companies that are expected to save the government billions of dollars. The list covers medications for conditions such as cancer, diabetes, lung conditions, and depression, the New York Times...
Coverage Details
Bias Distribution
- 70% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
